TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A prospective study of 194 people with knee osteoarthritis found that genicular artery embolization using dissolvable particles was associated with reduced pain and improved mobility. At the 12-month follow-up, 80% of patients assessed reported clinically meaningful pain relief; the study did not establish that the procedure slows joint damage or prove it is better than other treatments.
In a prospective study of 194 patients with knee osteoarthritis, researchers found that genicular artery embolization using rapidly dissolving particles was associated with less pain and better mobility, with 80% of patients assessed at one year reporting clinically meaningful pain relief. The findings, published in Radiology, suggest a possible nonsurgical option for people whose symptoms persist despite standard care, although the study does not show that the procedure prevents cartilage damage or replaces knee-replacement surgery.
The procedure, called genicular artery embolization (GAE), is performed by an interventional radiologist. A thin catheter is guided through an artery to selected small blood vessels around the knee. The clinician injects microscopic particles to reduce blood flow through targeted abnormal vessels, while aiming to preserve the knee’s normal circulation. It does not involve an open incision to replace the joint.
The study included 194 people with osteoarthritis-related knee pain that continued after at least three months of conventional care, including physical therapy, anti-inflammatory medication and knee injections. There were 114 women and 80 men; the median age was 69. Researchers used gelatin-based microspheres engineered to dissolve within hours, rather than particles intended to remain permanently in the vessels.
At the one-year follow-up, 80% of those assessed reported pain relief that met the study’s clinical threshold. The report also describes improvements in mobility and substantial reductions in pain. The supplied findings do not give the number of participants assessed at that follow-up, detailed numerical changes in pain scores, or a comparison with a control group. The results therefore describe outcomes among participants, not proof that GAE caused the improvement or outperformed other care.
A Possible Option Before Joint Replacement
Knee osteoarthritis can make walking, climbing stairs and standing difficult, and some people continue to have pain even after trying exercise-based care, medication or injections. For those patients, the treatment choices may feel limited, particularly if surgery is unsuitable for medical reasons or unwanted by the patient. A catheter-based procedure that does not replace the joint could offer another option for discussion with a specialist.
The findings are relevant because relief was reported at 12 months, rather than only immediately after treatment. But a year of follow-up does not establish how long benefits last beyond that point, whether repeat treatment is needed, or how GAE compares with surgery and other non-surgical approaches. The study supports further evaluation; it does not establish GAE as a standard alternative to joint replacement.
knee osteoarthritis pain relief supplements
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
How the Artery-Targeting Treatment Works
Osteoarthritis involves deterioration of cartilage, but pain can also be shaped by inflammation, changes in tissues around the joint and the activity of sensory nerves. The researchers’ approach focuses on abnormal blood-vessel growth around the inflamed joint lining. These vessels may interact with pain-signaling nerves, providing a rationale for targeting them rather than treating cartilage directly.
Earlier GAE research has examined different materials for blocking vessels. The particles in this study were gelatin-based and rapidly resorbable, designed to dissolve within hours. That is a feature of the treatment method, not evidence by itself that the approach is safer or more effective than other embolization materials. The study was conducted at a single center, and its participants had already tried at least three months of conventional care.
“We believe these results carry real weight because they come from real-world data.”
— Florian Nima Fleckenstein, M.D.
electric heating pad for knee pain
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Long-Term Effects Still Need Study
The reported outcomes do not establish whether GAE slows osteoarthritis progression, prevents further cartilage deterioration or reverses existing joint damage. The study authors’ suggestion that it might alter the disease course remains a hypothesis. Pain relief and mobility outcomes do not, on their own, show that the underlying joint condition changed.
The available report also leaves questions about how many patients completed the one-year assessment, the size of the measured changes, adverse events and durability beyond 12 months. Because this was a single-center study and the supplied account does not report a comparison group, it is not clear how results compare with placebo, continued conventional care or other procedures. The findings do not establish which patients are most likely to benefit.
As an affiliate, we earn on qualifying purchases.
Further Testing and Longer Follow-Up
Longer follow-up would help show whether the reported pain relief continues beyond a year and whether patients need another procedure. Studies that compare GAE with a control group or other treatments could better clarify how much improvement is attributable to the procedure, as well as assess side effects and which patient groups may benefit.
For now, the report adds evidence about a possible nonsurgical treatment for persistent knee pain, not a recommendation that patients replace established care or avoid surgery. People considering treatment should discuss available options and individual risks with a qualified clinician. The supplied study report does not specify a next trial, regulatory decision or timeline for wider adoption.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is genicular artery embolization?
Genicular artery embolization (GAE) is a catheter-based procedure in which a clinician directs tiny particles into selected blood vessels around the knee. The aim is to reduce flow through abnormal vessels linked to inflammation while preserving normal circulation.
How many patients reported pain relief at one year?
80% of patients assessed at the one-year follow-up reported clinically meaningful pain relief, according to the study report. The supplied information does not state how many of the original 194 participants were assessed at that point.
Does the study show that GAE stops arthritis from getting worse?
No. The study reported pain and mobility outcomes but did not demonstrate that GAE prevents cartilage deterioration, reverses joint damage or slows osteoarthritis progression. That possibility remains unconfirmed.
Is this procedure a proven replacement for knee surgery?
The findings do not establish GAE as a replacement for knee-replacement surgery. They suggest it may be another option for some people with ongoing symptoms, but the reported study does not show how it compares with surgery or other treatments.
How long did the reported benefit last?
The study reported outcomes through 12 months. Whether relief lasts longer, or whether repeat treatment is needed, is not clear from the supplied findings.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
